Literature DB >> 12147476

Comparison of in vitro cell culture and a mouse assay for measuring infectivity of Cryptosporidium parvum.

Paul A Rochelle1, Marilyn M Marshall, Jan R Mead, Anne M Johnson, Dick G Korich, Jeffrey S Rosen, Ricardo De Leon.   

Abstract

In vitro cell cultures were compared to neonatal mice for measuring the infectivity of five genotype 2 isolates of Cryptosporidium parvum. Oocyst doses were enumerated by flow cytometry and delivered to animals and cell monolayers by using standardized procedures. Each dose of oocysts was inoculated into up to nine replicates of 9 to 12 mice or 6 to 10 cell culture wells. Infections were detected by hematoxylin and eosin staining in CD-1 mice, by reverse transcriptase PCR in HCT-8 and Caco-2 cells, and by immunofluorescence microscopy in Madin-Darby canine kidney (MDCK) cells. Infectivity was expressed as a logistic transformation of the proportion of animals or cell culture wells that developed infection at each dose. In most instances, the slopes of the dose-response curves were not significantly different when we compared the infectivity models for each isolate. The 50% infective doses for the different isolates varied depending on the method of calculation but were in the range from 16 to 347 oocysts for CD-1 mice and in the ranges from 27 to 106, 31 to 629, and 13 to 18 oocysts for HCT-8, Caco-2, and MDCK cells, respectively. The average standard deviations for the percentages of infectivity for all replicates of all isolates were 13.9, 11.5, 13.2, and 10.7% for CD-1 mice, HCT-8 cells, Caco-2 cells, and MDCK cells, respectively, demonstrating that the levels of variability were similar in all assays. There was a good correlation between the average infectivity for HCT-8 cells and the results for CD-1 mice across all isolates for untreated oocysts (r = 0.85, n = 25) and for oocysts exposed to ozone and UV light (r = 0.89, n = 29). This study demonstrated that in vitro cell culture was equivalent to the "gold standard," mouse infectivity, for measuring the infectivity of C. parvum and should therefore be considered a practical and accurate alternative for assessing oocyst infectivity and inactivation. However, the high levels of variability displayed by all assays indicated that infectivity and disinfection experiments should be limited to discerning relatively large differences.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12147476      PMCID: PMC124000          DOI: 10.1128/AEM.68.8.3809-3817.2002

Source DB:  PubMed          Journal:  Appl Environ Microbiol        ISSN: 0099-2240            Impact factor:   4.792


  23 in total

1.  Community surveys of self-reported diarrhoea can dramatically overestimate the size of outbreaks of waterborne cryptosporidiosis.

Authors:  P R Hunter; Q Syed
Journal:  Water Sci Technol       Date:  2001       Impact factor: 1.915

2.  Comparison of Cryptosporidium parvum viability and infectivity assays following ozone treatment of oocysts.

Authors:  Z Bukhari; M M Marshall; D G Korich; C R Fricker; H V Smith; J Rosen; J L Clancy
Journal:  Appl Environ Microbiol       Date:  2000-07       Impact factor: 4.792

3.  Polymorphisms in the beta-tubulin gene of Cryptosporidium parvum differentiate between isolates based on animal host but not geographic origin.

Authors:  P A Rochelle; E M Jutras; E R Atwill; R De Leon; M H Stewart
Journal:  J Parasitol       Date:  1999-10       Impact factor: 1.276

4.  Quantitation of Cryptosporidium parvum infection in cell culture using a colorimetric in situ hybridization assay.

Authors:  P A Rochelle; D M Ferguson; A M Johnson; R De Leon
Journal:  J Eukaryot Microbiol       Date:  2001 Sep-Oct       Impact factor: 3.346

5.  Three-dimensional tissue assemblies: novel models for the study of Salmonella enterica serovar Typhimurium pathogenesis.

Authors:  C A Nickerson; T J Goodwin; J Terlonge; C M Ott; K L Buchanan; W C Uicker; K Emami; C L LeBlanc; R Ramamurthy; M S Clarke; C R Vanderburg; T Hammond; D L Pierson
Journal:  Infect Immun       Date:  2001-11       Impact factor: 3.441

6.  Complete development and long-term maintenance of Cryptosporidium parvum human and cattle genotypes in cell culture.

Authors:  N S Hijjawi; B P Meloni; U M Morgan; R C Thompson
Journal:  Int J Parasitol       Date:  2001-08       Impact factor: 3.981

7.  Inter-laboratory comparison of the CD-1 neonatal mouse logistic dose-response model for Cryptosporidium parvum oocysts.

Authors:  D G Korich; M M Marshall; H V Smith; J O'Grady; Z Bukhari; C R Fricker; J P Rosen; J L Clancy
Journal:  J Eukaryot Microbiol       Date:  2000 May-Jun       Impact factor: 3.346

8.  A most-probable-number assay for enumeration of infectious Cryptosporidium parvum oocysts.

Authors:  T R Slifko; D E Huffman; J B Rose
Journal:  Appl Environ Microbiol       Date:  1999-09       Impact factor: 4.792

9.  Quantitative flow cytometric evaluation of maximal Cryptosporidium parvum oocyst infectivity in a neonate mouse model.

Authors:  A Delaunay; G Gargala; X Li; L Favennec; J J Ballet
Journal:  Appl Environ Microbiol       Date:  2000-10       Impact factor: 4.792

10.  Complete development of Cryptosporidium in cell culture.

Authors:  W L Current; T B Haynes
Journal:  Science       Date:  1984-05-11       Impact factor: 47.728

View more
  40 in total

1.  Effects of the Norwegian winter environment on Giardia cysts and Cryptosporidium oocysts.

Authors:  L J Robertson; B K Gjerde
Journal:  Microb Ecol       Date:  2004-02-02       Impact factor: 4.552

2.  Assessment of methods for detection of infectious Cryptosporidium oocysts and Giardia cysts in reclaimed effluents.

Authors:  W Quintero-Betancourt; A L Gennaccaro; T M Scott; J B Rose
Journal:  Appl Environ Microbiol       Date:  2003-09       Impact factor: 4.792

3.  Determining UV inactivation of Toxoplasma gondii oocysts by using cell culture and a mouse bioassay.

Authors:  Michael W Ware; Swinburne A J Augustine; David O Erisman; Mary Jean See; Larry Wymer; Samuel L Hayes; J P Dubey; Eric N Villegas
Journal:  Appl Environ Microbiol       Date:  2010-06-11       Impact factor: 4.792

Review 4.  Cryptosporidiosis: environmental, therapeutic, and preventive challenges.

Authors:  S Collinet-Adler; H D Ward
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-06-04       Impact factor: 3.267

5.  In vitro determination of anticryptosporidial activity of phytogenic extracts and compounds.

Authors:  Klaus Teichmann; Maxime Kuliberda; Gerd Schatzmayr; Franz Hadacek; Anja Joachim
Journal:  Parasitol Res       Date:  2012-01-26       Impact factor: 2.289

6.  Quantification of in vitro and in vivo Cryptosporidium parvum infection by using real-time PCR.

Authors:  Nihal T Godiwala; Alain Vandewalle; Honorine D Ward; Brett A Leav
Journal:  Appl Environ Microbiol       Date:  2006-06       Impact factor: 4.792

7.  Comparison of levels of inactivation of two isolates of Giardia lamblia cysts by UV light.

Authors:  Dong Li; Stephen A Craik; Daniel W Smith; Miodrag Belosevic
Journal:  Appl Environ Microbiol       Date:  2007-02-02       Impact factor: 4.792

8.  Quantitative-PCR assessment of Cryptosporidium parvum cell culture infection.

Authors:  George D Di Giovanni; Mark W LeChevallier
Journal:  Appl Environ Microbiol       Date:  2005-03       Impact factor: 4.792

9.  Cell culture-Taqman PCR assay for evaluation of Cryptosporidium parvum disinfection.

Authors:  Alexandra R Keegan; Stella Fanok; Paul T Monis; Christopher P Saint
Journal:  Appl Environ Microbiol       Date:  2003-05       Impact factor: 4.792

10.  Quantitative evaluation of infectivity change of Cryptosporidium parvum after gamma irradiation.

Authors:  Soo-Ung Lee; Mikyo Joung; Taekyoung Nam; Woo-Yoon Park; Jae-Ran Yu
Journal:  Korean J Parasitol       Date:  2009-03-12       Impact factor: 1.341

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.